NHS National Framework for Ferric Carboxymaltose injection

Description

Project title: NHS National Framework for Ferric Carboxymaltose Injection Offer reference number: CM/TNS/26/5743 Period of framework agreement: Dates detailed below, with an option or options to extend (at the discretion of the Authority) up to a maximum of 24 months. CM/TNS/26/5743 Ferric Carboxymaltose Injection Lot 1 CESW 01/03/2027 to 31/01/2029 (23 months) Lot 2 NWLN 01/03/2027 to 31/05/2028 (15 months) Lot 3 LSNE 01/03/2027 to 31/05/2028 (15 months) Published By: Medicines Procurement and Supply Chain - NHS Medicines Value & Access, NHS England

Key facts

Procedure

Open procedure

Framework agreement

Yes — a framework or dynamic purchasing system, not a single contract

Lots

1

Contact

katie.noonan@nhs.net

Contract period

1 Mar 2027 → 31 Jan 2029

Value incl. VAT

£36m

Category

goods

Awarded suppliers

• Vifor Pharma UK Limited · GB-COH-06514784 · UKI31, GB
• VIATRIS UK HEALTHCARE LIMITED · GB-COH-09189103 · UKH23, GB
• TEVA UK LIMITED · GB-COH-00302461 · UKE45, GB

Bid competition

Who else bid, as published on the notice. A bid is an offer, not money paid: nothing in this section is an award, and a firm named here was not necessarily paid anything.